Balleza Alejandri L, Grover Paez F, Gonzalez Campos E, Ramos Becerra C, Cardona Munoz E, Pascoe Gonzalez S
J Cardiovasc Dev Dis. 2024; 11(6).
PMID: 38921682
PMC: 11204032.
DOI: 10.3390/jcdd11060182.
Pico-Guzman F, Martinez-Montanez O, Ruelas-Barajas E, Hernandez-Avila M
Rev Med Inst Mex Seguro Soc. 2023; 60(Suppl 2):S86-S95.
PMID: 36795992
PMC: 10629407.
Martinez-Ramirez O, Salazar-Pina A, Ceron-Ramirez X, Rubio-Lightbourn J, Torres-Romero F, Casas-Avila L
Nutrients. 2022; 14(23).
PMID: 36501225
PMC: 9737482.
DOI: 10.3390/nu14235195.
Lopez Sanchez G, Lopez-Bueno R, Villasenor-Mora C, Pardhan S
Front Nutr. 2022; 9:894904.
PMID: 35845804
PMC: 9280272.
DOI: 10.3389/fnut.2022.894904.
Gharaibeh M, Elheis M, Khasawneh R, Al-Omari M, Jibril M, Dilki K
Int J Gen Med. 2022; 15:5103-5110.
PMID: 35620646
PMC: 9128829.
DOI: 10.2147/IJGM.S360851.
Health-care guidelines and policies during the COVID-19 pandemic in Mexico: A case of health-inequalities.
Bautista-Gonzalez E, Werner-Sunderland J, Perez-Duarte Mendiola P, Esquinca-Enriquez-de-la-Fuente C, Bautista-Reyes D, Maciel-Gutierrez M
Health Policy Open. 2021; 2:100025.
PMID: 33521627
PMC: 7836807.
DOI: 10.1016/j.hpopen.2020.100025.
Olfactory Dysfunction in a Mexican Population Outside of COVID-19 Pandemic: Prevalence and Associated Factors (the OLFAMEX Study).
Castillo-Lopez I, Govea-Camacho L, Rodriguez-Torres I, Recio-Macias D, Alobid I, Mullol J
Curr Allergy Asthma Rep. 2020; 20(12):78.
PMID: 33161494
PMC: 7649040.
DOI: 10.1007/s11882-020-00975-9.
Non-communicable diseases and inequalities increase risk of death among COVID-19 patients in Mexico.
Gutierrez J, Bertozzi S
PLoS One. 2020; 15(10):e0240394.
PMID: 33031467
PMC: 7544063.
DOI: 10.1371/journal.pone.0240394.
Association of serum levels of secreted frizzled-related protein 5 and Wnt member 5a with glomerular filtration rate in patients with type 2 diabetes mellitus and chronic renal disease: a cross-sectional study.
Baez I, Castro D, Gutierrez S, Lopez E, Lemarroy A, Suarez L
Sao Paulo Med J. 2020; 138(2):133-139.
PMID: 32491086
PMC: 9662847.
DOI: 10.1590/1516-3180.2019.0304.r2.09122019.
Positive health beliefs are associated with improvement of glycated hemoglobin and lipid profiles in Mexican patients with type 2 diabetes mellitus: a cross-sectional study.
Munoz-Torres A, Medina-Bravo P, Valerio-Perez B, Mendoza-SalmerOn G, Pena J, Velazquez-Lopez L
BMC Public Health. 2020; 20(1):761.
PMID: 32448139
PMC: 7245761.
DOI: 10.1186/s12889-020-08866-4.
Prevalence of previously diagnosed diabetes and glycemic control strategies in Mexican adults: ENSANUT-2016.
Campos-Nonato I, Ramirez-Villalobos M, Flores-Coria A, Valdez A, Monterrubio-Flores E
PLoS One. 2020; 15(4):e0230752.
PMID: 32298264
PMC: 7162504.
DOI: 10.1371/journal.pone.0230752.
Effect on Adipose Tissue of Diabetic Mice Supplemented with n-3 Fatty Acids Extracted from Microalgae.
Gutierrez-Pliego L, Martinez-Carrillo B, Resendiz-Albor A, Valdes-Ramos R
Endocr Metab Immune Disord Drug Targets. 2020; 20(5):728-735.
PMID: 32053089
PMC: 7360907.
DOI: 10.2174/1871530320666200213111452.
Structure-Activity Relationship Study of Acyclic Terpenes in Blood Glucose Levels: Potential α-Glucosidase and Sodium Glucose Cotransporter (SGLT-1) Inhibitors.
Valdes M, Calzada F, Mendieta-Wejebe J
Molecules. 2019; 24(22).
PMID: 31698833
PMC: 6891574.
DOI: 10.3390/molecules24224020.
[Global prevalence of type 2 diabetes mellitus and its relationship with the Human Development IndexPrevalência mundial da diabetes mellitus tipo 2 e sua relação com o índice de desenvolvimento humano].
Mendoza Romo M, Padron Salas A, Cossio Torres P, Soria Orozco M
Rev Panam Salud Publica. 2019; 41:e103.
PMID: 31384252
PMC: 6645285.
DOI: 10.26633/RPSP.2017.103.
Sex disparities in the epidemic of type 2 diabetes in Mexico: national and state level results based on the Global Burden of Disease Study, 1990-2017.
Davila-Cervantes C, Agudelo-Botero M
Diabetes Metab Syndr Obes. 2019; 12:1023-1033.
PMID: 31360070
PMC: 6625746.
DOI: 10.2147/DMSO.S205198.
Frequency of (, and ) allelic variants, and their clinical implications, among Mexican patients with diabetes mellitus type 2 undergoing treatment with glibenclamide and metformin.
Cuautle-Rodriguez P, Rodriguez-Rivera N, de Andres F, Castillo-Najera F, LLerena A, Molina-Guarneros J
Biomed Rep. 2019; 10(5):283-295.
PMID: 31086662
PMC: 6489535.
DOI: 10.3892/br.2019.1204.
Diabetes, undernutrition, migration and indigenous communities: tuberculosis in Chiapas, Mexico.
Rashak H, Sanchez-Perez H, Abdelbary B, Bencomo-Alerm A, Enriquez-Rios N, Gomez-Velasco A
Epidemiol Infect. 2019; 147:e71.
PMID: 30869023
PMC: 6518577.
DOI: 10.1017/S0950268818003461.
Lack of Association of Coffee Consumption with the Prevalence of Self-Reported Type 2 Diabetes Mellitus in a Mexican Population: A Cross-Sectional Study.
Gil-Madrigal A, Gonzalez-Castro T, Tovilla-Zarate C, Aguilar-Velazquez D, Gomez-Peralta T, Juarez-Rojop I
Int J Environ Res Public Health. 2018; 15(10).
PMID: 30257442
PMC: 6210689.
DOI: 10.3390/ijerph15102100.
Collaborative research and actions on both sides of the US-Mexico border to counteract type 2 diabetes in people of Mexican origin.
Barquera S, Schillinger D, Aguilar-Salinas C, Schenker M, Rodriguez L, Hernandez-Alcaraz C
Global Health. 2018; 14(1):84.
PMID: 30134925
PMC: 6104005.
DOI: 10.1186/s12992-018-0390-5.
Mexico's household health expenditure on diabetes and hypertension: What is the additional financial burden?.
Gutierrez J, Garcia-Saiso S, Aracena B
PLoS One. 2018; 13(7):e0201333.
PMID: 30052668
PMC: 6063432.
DOI: 10.1371/journal.pone.0201333.
